These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34048861)

  • 1. Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients.
    Cornberg M; Eberhardt CS
    J Hepatol; 2021 Aug; 75(2):265-266. PubMed ID: 34048861
    [No Abstract]   [Full Text] [Related]  

  • 2. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
    Reuken PA; Albers S; Rauchfuss F; Strnad P; Settmacher U; Trautwein C; Stallmach A; Bruns T
    Z Gastroenterol; 2021 Dec; 59(12):1288-1296. PubMed ID: 34670294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.
    Toniutto P; Aghemo A; Grossi P; Burra P;
    Dig Liver Dis; 2021 Oct; 53(10):1232-1234. PubMed ID: 34393073
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
    Dumortier J
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101743. PubMed ID: 34146727
    [No Abstract]   [Full Text] [Related]  

  • 5. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.
    Alqahtani SA; Barry M; Memish Z; Hashim A; Alfares MA; Alghamdi SA; Al-Hamoudi WK; Al-Judaibi B; Alhazzani W; Al-Tawfiq JA; Abaalkhail F
    Saudi J Gastroenterol; 2021; 27(4):201-207. PubMed ID: 34100388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High acceptance rate of COVID-19 vaccination in liver transplant recipients.
    Giannini EG; Marenco S
    J Hepatol; 2021 Aug; 75(2):483-484. PubMed ID: 34052253
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study.
    Wang J; Hou Z; Liu J; Gu Y; Wu Y; Chen Z; Ji J; Diao S; Qiu Y; Zou S; Zhang A; Zhang N; Wang F; Li X; Wang Y; Liu X; Lv C; Chen S; Liu D; Ji X; Liu C; Ren T; Sun J; Zhao Z; Wu F; Li F; Wang R; Yan Y; Zhang S; Ge G; Shao J; Yang S; Liu C; Huang Y; Xu D; Li X; Ai J; He Q; Zheng MH; Zhang L; Xie Q; Rockey DC; Fallowfield JA; Zhang W; Qi X
    J Hepatol; 2021 Aug; 75(2):439-441. PubMed ID: 33905793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection in liver transplant recipients: A complex relationship.
    Alberca RW; Benard G; Alberca GGF; Sato MN
    World J Gastroenterol; 2021 Nov; 27(44):7734-7738. PubMed ID: 34908810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Disease 2019 Messenger RNA Vaccine and Liver Transplant Recipients.
    Mungmunpuntipantip R; Wiwanitkit V
    Liver Transpl; 2022 Jan; 28(1):140. PubMed ID: 34506684
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccination in our transplant recipients: The time is now.
    Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
    J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.
    Burra P; Russo FP
    Liver Int; 2022 Jun; 42(6):1225-1228. PubMed ID: 35678039
    [No Abstract]   [Full Text] [Related]  

  • 14. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for.
    Thompson MA; Martinez-Barbini F; Mendizabal M
    Ann Hepatol; 2023; 28(3):101081. PubMed ID: 36882137
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
    Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Laurent C; Etienne I; Lemoine M; Lebourg L; Hanoy M; Le Roy F; Nezam D; Farce F; Plantier JC; Boyer O; Guerrot D; Candon S
    Kidney Int; 2021 Dec; 100(6):1337-1340. PubMed ID: 34619232
    [No Abstract]   [Full Text] [Related]  

  • 18. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1498-1500. PubMed ID: 33887315
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.
    Kamar N; Abravanel F; Marion O; Romieu-Mourez R; Couat C; Del Bello A; Izopet J
    JAMA Netw Open; 2021 Nov; 4(11):e2136030. PubMed ID: 34817587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A
    N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.